Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
170.31
+2.35 (1.40%)
Apr 3, 2025, 1:49 PM EDT - Market open
Quest Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 9,872 | 9,252 | 9,883 | 10,788 | 9,437 | Upgrade
|
| Revenue Growth (YoY) | 6.70% | -6.39% | -8.39% | 14.32% | 22.15% | Upgrade
|
| Cost of Revenue | 6,601 | 6,183 | 6,431 | 6,571 | 5,795 | Upgrade
|
| Gross Profit | 3,271 | 3,069 | 3,452 | 4,217 | 3,642 | Upgrade
|
| Selling, General & Admin | 1,733 | 1,615 | 1,838 | 1,723 | 1,545 | Upgrade
|
| Other Operating Expenses | 1 | 1 | -3 | -2 | 6 | Upgrade
|
| Operating Expenses | 1,861 | 1,724 | 1,955 | 1,824 | 1,654 | Upgrade
|
| Operating Income | 1,410 | 1,345 | 1,497 | 2,393 | 1,988 | Upgrade
|
| Interest Expense | -226 | -163 | -148 | -152 | -166 | Upgrade
|
| Interest & Investment Income | 25 | 11 | 10 | 1 | 3 | Upgrade
|
| Earnings From Equity Investments | 19 | 26 | 44 | 78 | 75 | Upgrade
|
| Other Non Operating Income (Expenses) | 22 | 20 | -55 | 55 | 76 | Upgrade
|
| EBT Excluding Unusual Items | 1,250 | 1,239 | 1,348 | 2,375 | 1,976 | Upgrade
|
| Merger & Restructuring Charges | -54 | -72 | -69 | -12 | -14 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 314 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -3 | Upgrade
|
| Other Unusual Items | -2 | -11 | - | - | - | Upgrade
|
| Pretax Income | 1,194 | 1,156 | 1,279 | 2,677 | 1,959 | Upgrade
|
| Income Tax Expense | 273 | 248 | 264 | 597 | 460 | Upgrade
|
| Earnings From Continuing Operations | 921 | 908 | 1,015 | 2,080 | 1,499 | Upgrade
|
| Net Income to Company | 921 | 908 | 1,015 | 2,080 | 1,499 | Upgrade
|
| Minority Interest in Earnings | -50 | -54 | -69 | -85 | -68 | Upgrade
|
| Net Income | 871 | 854 | 946 | 1,995 | 1,431 | Upgrade
|
| Preferred Dividends & Other Adjustments | 5 | 4 | 4 | 7 | 6 | Upgrade
|
| Net Income to Common | 866 | 850 | 942 | 1,988 | 1,425 | Upgrade
|
| Net Income Growth | 1.99% | -9.72% | -52.58% | 39.41% | 66.78% | Upgrade
|
| Shares Outstanding (Basic) | 111 | 112 | 116 | 125 | 134 | Upgrade
|
| Shares Outstanding (Diluted) | 113 | 113 | 118 | 128 | 136 | Upgrade
|
| Shares Change (YoY) | - | -4.24% | -7.81% | -5.88% | - | Upgrade
|
| EPS (Basic) | 7.80 | 7.59 | 8.12 | 15.90 | 10.63 | Upgrade
|
| EPS (Diluted) | 7.69 | 7.49 | 7.97 | 15.55 | 10.47 | Upgrade
|
| EPS Growth | 2.67% | -6.02% | -48.75% | 48.52% | 66.80% | Upgrade
|
| Free Cash Flow | 909 | 864 | 1,314 | 1,830 | 1,587 | Upgrade
|
| Free Cash Flow Per Share | 8.04 | 7.65 | 11.14 | 14.30 | 11.67 | Upgrade
|
| Dividend Per Share | 3.000 | 2.840 | 2.640 | 2.480 | 2.240 | Upgrade
|
| Dividend Growth | 5.63% | 7.58% | 6.45% | 10.71% | 5.66% | Upgrade
|
| Gross Margin | 33.13% | 33.17% | 34.93% | 39.09% | 38.59% | Upgrade
|
| Operating Margin | 14.28% | 14.54% | 15.15% | 22.18% | 21.07% | Upgrade
|
| Profit Margin | 8.77% | 9.19% | 9.53% | 18.43% | 15.10% | Upgrade
|
| Free Cash Flow Margin | 9.21% | 9.34% | 13.30% | 16.96% | 16.82% | Upgrade
|
| EBITDA | 1,903 | 1,784 | 1,934 | 2,801 | 2,349 | Upgrade
|
| EBITDA Margin | 19.28% | 19.28% | 19.57% | 25.96% | 24.89% | Upgrade
|
| D&A For EBITDA | 493 | 439 | 437 | 408 | 361 | Upgrade
|
| EBIT | 1,410 | 1,345 | 1,497 | 2,393 | 1,988 | Upgrade
|
| EBIT Margin | 14.28% | 14.54% | 15.15% | 22.18% | 21.07% | Upgrade
|
| Effective Tax Rate | 22.86% | 21.45% | 20.64% | 22.30% | 23.48% | Upgrade
|
| Advertising Expenses | 28 | 31 | 74 | 78 | 38 | Upgrade
|
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.